Stresin 20 mg (Capsule (Delayed Release))
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Duloxetine hydrochloride |
Company | Unimed unihealth pharmaceuticals ltd |
Also available as |
Indications
- Major Depressive Disorder (MDD)
- Generalized Anxiety Disorder (GAD)
- Diabetic Peripheral Neuropathic Pain (DPNP)
- Fibromyalgia
- Chronic Musculoskeletal Pain
Pharmacology
- Selective serotonin and norepinephrine reuptake inhibitor (SSNRI)
- Less potent inhibitor of dopamine reuptake
- No significant affinity for various receptors
- Mainly eliminated through hepatic metabolism
Dosage & Administration
- Starting Dose: 40 mg/day to 60 mg/day for MDD
- Target Dose: 60 mg/day for GAD
- Maximum Dose: 120 mg/day for MDD and GAD
- Starting Dose: 60 mg/day for DPNP
- Target Dose: 60 mg/day for DPNP
- Maximum Dose: 60 mg/day for DPNP
- Starting Dose: 30 mg/day for Fibromyalgia
- Target Dose: 60 mg/day for Fibromyalgia
- Maximum Dose: 60 mg/day for Fibromyalgia
- Starting Dose: 30 mg/day for Chronic Musculoskeletal Pain
- Target Dose: 60 mg/day for Chronic Musculoskeletal Pain
- Maximum Dose: 60 mg/day for Chronic Musculoskeletal Pain
- No evidence for benefit above 60 mg/day
- Gradual dose reduction recommended
- Avoid concomitant use with certain inhibitors
Interaction
- Metabolism via CYP1A2 and CYP2D6 isozymes
- Increased levels when co-administered with specific inhibitors
Contraindications
- Hypersensitivity to drug or inactive ingredients
- Bipolar depression
- Substantial alcohol use or chronic liver disease
- Use caution in patients with narrow-angle glaucoma
Side Effects
- Nausea
- Dizziness
- Dry mouth
- Constipation
- Decreased appetite
- Fatigue
- Somnolence
- Increased sweating
- Hyperhidrosis
- Asthenia
- Slight increase in blood pressure
- No clinically significant differences in cardiac intervals
Pregnancy & Lactation
- Pregnancy Category C
- Use during pregnancy only if benefit justifies risk
- Effect on labor and delivery unknown
- Not recommended during lactation
Precautions & Warnings
- Monitoring for clinical worsening, suicidality, and behavioral changes
- Monitoring blood pressure
- Caution with concomitant use of NSAIDs, aspirin, or coagulation-affecting drugs
- Caution in patients with history of mania or seizure disorder
Use in Special Populations
- Safety and efficacy not established in pediatric patients
Overdose Effects
- Limited clinical experience with overdose
- No specific antidote
- General measures for overdose management
- Monitoring airway, oxygenation, ventilation, cardiac rhythm and vital signs
- Avoid induction of emesis
- Consider gastric lavage and activated charcoal
Therapeutic Class
- Serotonin-norepinephrine reuptake inhibitor (SNRI)
Storage Conditions
- Do not store above 30°C
- Keep away from light
- Keep out of reach of children
Related Brands
- Xinolax DR 20 mg (Capsule (Delayed Release)) - opsonin-pharma-ltd
- Xinolax DR 30 mg (Capsule (Delayed Release)) - opsonin-pharma-ltd
- Xinolax DR 60 mg (Capsule (Delayed Release)) - opsonin-pharma-ltd
- Loxetine 20 mg (Tablet (Delayed Release)) - aci-limited
- Loxetine 30 mg (Tablet (Delayed Release)) - aci-limited